Rapid eye movement sleep behavior disorder: Current knowledge and future directions

Sleep Medicine

Volumn 14, Issue 8, 2013, Pages 699-702

  Schenck, Carlos H ^a   Trenkwalder, Claudia ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; AMFEBUTAMONE; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; GLUTAMIC ACID; GLYCINE; MELATONIN; OREXIN;

ANIMAL BEHAVIOR; AUTOPSY; CATAPLEXY; COMORBIDITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEMENTIA; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; DRUG WITHDRAWAL; ECHOGRAPHY; EDITORIAL; ELECTROMYOGRAPHY; HUMAN; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; METHODOLOGY; MOOD DISORDER; MUSCLE ATONIA; MUSCLE TWITCH; NARCOLEPSY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARASOMNIA; PARASOMNIA WITHOUT ATONIA; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; RISK FACTOR; SHY DRAGER SYNDROME; SYMPOSIUM;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; HUMANS; POLYSOMNOGRAPHY; REM SLEEP BEHAVIOR DISORDER;

EID: 84881551513     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.04.011     Document Type: Editorial

References (43)

1. Schenck C.H., Bundlie S.R., Ettinger M.G., Mahowald M.W. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986, 9(2):293-308.
2. Schenck C.H., Bundlie S.R., Patterson A.L., Mahowald M.W. REM sleep behavior disorder: a treatable parasomnia affecting older adults. JAMA 1987, 257:1786-1789.
3. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996, 46(2):388-393.
4. Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of Parkinsonism or dementia in 81% of older males originally diagnosed with idiopathic REM sleep behavior disorder: 16 year update on a previously reported series. Sleep Med 2013;14(8):744-8.
5. Iranzo A., Molinuevo J.L., Santamaria J., Serradell M., Marti M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behavior disorder as an early marker for neurodegenerative disorder: a descriptive study. Lancet Neurol 2006, 5:572-577.
6. Iranzo A., Tolosa E., Gelpi E. Neurodegenerative disease status and post-mortem pathology in isolated rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 2013, [Epub ahead of print]. 10.1016/S1474-4422(13)70056-5.
7. Postuma R.B., Gagnon J.F., Vendette M., Fantini M.L., Massicotte-Marquez J., Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009, 72(15):1296-1300.
8. Postuma R.B., Gagnon J.F., Montplaisir J.Y. REM sleep behavior disorder: from dreaming to neurodegeneration. Neurobiol Dis 2012, 46(3):553-558.
9. Postuma R.B., Montplaisir J.Y., Wolfson C., Pelletier A., Dauvilliers Y., Oertel W., et al. Environmental risk factors for REM sleep behavior disorder-a multicentere case-control study. Neurology 2012, 79(5):428-434.
10. Schenck CH, Montplaisir J, Frauscher B, et al. REM sleep behavior disorder (RBD): devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement by the International RBD Study Group. Sleep Med 2013;14(8):795-806.
11. Dauvilliers Y., Postuma R.B., Ferini-Strambi L., et al. Family history of idiopathic REM behavior disorder: a multicenter case-control study. Neurology 2013, 80:1-3.
12. Schenck C.H., Mahowald M.W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002, 25(2):120-138.
13. Schenck C.H., Lee S.A., Bornemann M.A., Mahowald M.W. Potentially lethal behaviors associated with rapid eye movement sleep behavior disorder: review of the literature and forensic implications. J Forensic Sci 2009, 54(6):1475-1484.
14. American Academy of Sleep Medicine International classification of sleep disorders: diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester (IL). 2nd ed.
15. Shimizu T., Inami Y., et al. REM sleep without atonia (stage 1-REM) and its relation to delirious behavior durung sleep in patients with degenerative diseases involving the brain stem. Jpn J Neurol Psychiat 1990, 44:681-691.
16. Guilleminault C., Raynal D., Takahashi S., Carskadon M., Dement W. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 1976, 54:71-87.
17. Schenck C.H., Mahowald M.W., Kim S.W., O'Connor K.A., Hurwitz T.D. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992, 15:226-235.
18. Mahowald M., Schenck C.H. REM sleep parasomnias. Principles and practice of sleep medicine 2010, 1083-1097. Elsevier Saunders, Philadelphia, Pennsylvania. 5th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
19. Jouvet M., Delorme F. Locus coeruleus et sommeil paradoxal. CR Soc Biol 1965, 159:895-899.
20. Schenck C.H., Boeve B.F. The strong presence of REM sleep behavior disorder in PD: clinical and research implications [editorial]. Neurology 2011, 77(11):1030-1032.
21. Brooks P.L., Peever J.H. Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice. J Neurosci 2011, 31(19):7111-7121. [Erratum in: J Neurosci 2011; 31(25): 9440].
22. Turek F.W., Dugovic C. RBD-an emerging clue to neurodegenerative disorders. Sleep 2005, 28(8):920-921.
23. Mahowald M.W., Schenck C.H. The REM sleep behavior disorder odyssey [Editorial]. Sleep Med Rev 2009, 13:381-384.
24. Ramaligam V, Saper CB, Lu J. Perspectives on the REM sleep switch in REM sleep behavior disorder (RBD). Sleep Med 2013;14(8):707-13.
25. Luppi P-H, Fort P, Clement O, Valencia S. New aspects in the pathophysiology of RBD: the potential role glutamate, GABA and glycine. Sleep Med 2013;14(8):714-8.
26. Hsieh K-C, Lai YY, Nguyen D, Siegel JM. New pathways and data on RBD in a rat model. Sleep Med 2013;14(8):719-28.
27. Iranzo A., Graus F., Clover L., Morera J., Bruna J., Vilar C., et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol 2005, 59:178-182.
28. Frauscher B, Ehrmann L, Hogl B. Defining muscle activities for assessment of rapid eye movement sleep behavior disorder: from a qualitative to a quantitative diagnostic level. Sleep Med 2013;14(8):729-33.
29. Lam S-P, Li SX, Zhang J, Wing YK. Development of scales for assessment of REM sleep behavior disorder (RBD). Sleep Med 2013;14(8):734-8.
30. Miyamoto M, Miyamoto T. Neuroimaging studies in of RBD: transcranial ultrasound and SPECT/PET data. Sleep Med 2013;14(8):739-43.
31. Postuma R, Gagnon JFG, Montplaisir J. RBD as a biomarker for neurodegeneration: the past 10 years. Sleep Med 2013;14(8):763-7.
32. Claassen D.O., Josephs K.A., Ahlskog J.E., Silber M.H., Tippmann-Peikert M., Boeve B.F. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010, 75(6):494-499.
33. de Cock VC. Recent data on RBD in patients with PD: analysis of behaviours, movements, and periodic leg movements. Sleep Med 2013;14(8):749-53.
34. Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder with or without a coexisting neurologic disorder: clinicopathologic correlations in 171 cases. Sleep Med 2013;14(8):754-62.
35. Verhave P.S., Jongsma M.J., van den Berg R.M., et al. REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease. Sleep Biol Rhythms 2011, 34(8):1119-1125.
36. Schenck C.H., Mahowald M.W. Subclinical REM sleep behavior disorder and its clinical and research implications. Sleep 2008, 31(12):1627.
37. Ju Y-E. RBD in adults younger than 50 years old. Sleep Med 2013;14(8):768-74.
38. Schenck C.H., Garcia-Rill E., Segall M., Noreen H., Mahowald M.W. HLA class II genes associated with REM sleep behavior disorder. Ann Neurol 1996, 39:261-263.
39. Dauvilliers Y, Jennum P, Plazzi G. REM sleep behaviour and REM sleep without atonia in narcolepsy. Sleep Med 2013;14(8):775-81.
40. Anderson K.N., Vincent A., Smith I.E., Shneerson J.M. Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder. Eur J Neurol 2010, 17(8):1105-1107.
41. Jennum P, Mayer GM, Ju Y-EY, Postuma RP. Morbidities in rapid eye movement sleep behaviour disorder (RBD) and Comorbidities. Sleep Med 2013;14(8:)782-7.
42. Sixel-Döring F., Trautmann E., Mollenhauer B., Trenkwalder C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011, 77:1048-1054.
43. Lam S-P, Li SX, L, Chan JWY, et al. Does REM sleep behavior disorder exist in psychiatric populations? A clinical and polysomnographic case-control study. Sleep Med 2013;14(8):788-94.